These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33121835)

  • 1. Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients.
    Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Saghir Afifeh AM; Viglione F; Suryapranata H; Marcolongo M; De Luca G;
    Clin Nutr; 2021 Apr; 40(4):2228-2236. PubMed ID: 33121835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of vitamin D activation in patients with acute coronary syndromes and its correlation with inflammatory markers.
    Saghir Afifeh AM; Verdoia M; Nardin M; Negro F; Viglione F; Rolla R; De Luca G;
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):36-43. PubMed ID: 33308994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography.
    Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Afifeh AMS; Viglione F; Suryapranata H; Marcolongo M; De Luca G;
    Eur J Clin Invest; 2021 Apr; 51(4):e13439. PubMed ID: 33112413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Afifeh AMS; Viglione F; Suryapranata H; Marcolongo M; De Luca G;
    Eur J Intern Med; 2021 Jan; 83():62-67. PubMed ID: 32830035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention.
    Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Saghir Afifeh AM; Viglione F; Suryapranata H; Marcolongo M; De Luca G;
    Pharmacol Res; 2020 Oct; 160():105158. PubMed ID: 32841717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial.
    Meireles MS; Kamimura MA; Dalboni MA; Giffoni de Carvalho JT; Aoike DT; Cuppari L
    Clin Nutr; 2016 Dec; 35(6):1251-1258. PubMed ID: 27161894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
    Verdoia M; Pergolini P; Nardin M; Rolla R; Negro F; Kedhi E; Suryapranata H; Marcolongo M; Carriero A; De Luca G;
    Vascul Pharmacol; 2019 Sep; 120():106564. PubMed ID: 31176855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D deficiency is independently associated with the extent of coronary artery disease.
    Verdoia M; Schaffer A; Sartori C; Barbieri L; Cassetti E; Marino P; Galasso G; De Luca G
    Eur J Clin Invest; 2014 Jul; 44(7):634-42. PubMed ID: 24829065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases.
    Sainaghi PP; Bellan M; Carda S; Cerutti C; Sola D; Nerviani A; Molinari R; Cisari C; Avanzi GC
    Rheumatol Int; 2012 Nov; 32(11):3365-72. PubMed ID: 22045518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients.
    Rousseau AF; Damas P; Ledoux D; Cavalier E
    Burns; 2014 Aug; 40(5):865-70. PubMed ID: 24462294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention.
    Verdoia M; Viglione F; Boggio A; Stefani D; Panarotto N; Malabaila A; Rolla R; Soldà PL; De Luca G;
    Vascul Pharmacol; 2021 Oct; 140():106897. PubMed ID: 34274529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
    Nardin M; Verdoia M; Schaffer A; Barbieri L; Marino P; De Luca G;
    Atherosclerosis; 2016 Jul; 250():114-21. PubMed ID: 27205868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D levels in Swiss breast cancer survivors.
    Baumann M; Dani SU; Dietrich D; Hochstrasser A; Klingbiel D; Mark MT; Riesen WF; Ruhstaller T; Templeton AJ; Thürlimann B
    Swiss Med Wkly; 2018; 148():w14576. PubMed ID: 29376548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature.
    Giuggioli D; Colaci M; Cassone G; Fallahi P; Lumetti F; Spinella A; Campomori F; Manfredi A; Manzini CU; Antonelli A; Ferri C
    Clin Rheumatol; 2017 Mar; 36(3):583-590. PubMed ID: 28070764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
    Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?
    Muscogiuri G; Nuzzo V; Gatti A; Zuccoli A; Savastano S; Di Somma C; Pivonello R; Orio F; Colao A
    Endocrine; 2016 Feb; 51(2):268-73. PubMed ID: 25931413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum active 1,25(OH)
    Playford MP; Dey AK; Zierold C; Joshi AA; Blocki F; Bonelli F; Rodante JA; Harrington CL; Rivers JP; Elnabawi YA; Chen MY; Ahlman MA; Teague HL; Mehta NN
    Atherosclerosis; 2019 Oct; 289():44-50. PubMed ID: 31450013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
    de Carvalho JTG; Schneider M; Cuppari L; Grabulosa CC; Cendoroglo M; Dalboni MA
    J Ren Nutr; 2019 Sep; 29(5):454-461. PubMed ID: 30686751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.